Samsung

Samsung is a BTW intelligence profile anchored in public article evidence, object context, event links, and relationship watchpoints.

Samsung Medison announces acquisition of French AI ultrasound startup Sonio for $92.7 million. Acquisition aims to integrate Sonio’s advanced AI algorithms into Samsung Medison’s ultrasound systems. Move underscores Samsung Medison’s commitment to advancing innovation in medical imaging technology. Samsung Medison , a provider of medical imaging equipment, has unveiled plans to acquire Sonio , a French artificial intelligence (AI) ultrasound startup, for a reported sum of $92.7 million. Strategic expansion The announcement, made by Samsung Medison’s executive leadership, aimed at diversifying its portfolio and enhancing its capabilities in ultrasound imaging. Sonio, renowned for its AI algorithms designed to improve diagnostic accuracy and efficiency in ultrasound scans, presents an opportunity for Samsung Medison to augment its offerings and better meet the evolving needs of healthcare providers worldwide. Also read: AI advances bring Samsung’s memory chip business back to life Enhanced diagnostic capabilities The acquisition is poised to facilitate synergies between Samsung Medison’s expertise in ultrasound hardware and Sonio’s AI-powered software solutions. By combining forces, the two entities aim to develop next-generation ultrasound systems equipped with advanced AI functionalities, empowering healthcare professionals with enhanced diagnostic capabilities and streamlined workflows. Also read: Samsung says AI will drive technology demand in second half Investment in innovation Furthermore, the acquisition underscores Samsung Medison’s commitment to fostering innovation and collaboration within the global healthcare ecosystem. By integrating Sonio’s AI technology into its product lineup, Samsung Medison seeks to drive transformative change in ultrasound imaging, ultimately improving patient outcomes and advancing the standard of care. Samsung Medison’s leadership expressed optimism about the alignment between the two companies and the potential impact on medical imaging. They emphasised a shared vision of using technology to address healthcare needs and reiterated Samsung Medison’s commitment to providing solutions that benefit healthcare providers globally. As Samsung Medison finalises the acquisition of Sonio, attention now shifts to the potential synergies and innovative advancements in ultrasound imaging. With healthcare technology evolving rapidly, Samsung Medison’s investment in AI-driven innovation underscores its dedication to facilitating positive changes in the healthcare industry.